OncoDNA is enlarging four-fold its panel of genes to offer the biggest accuracy on mutational burden calculation for your patients.
And even more price effective!
Discover our new Product Panel release for Solid Tumors - OncoDEEP [...] (Read more)
The mass of molecular data you are collecting for a single patient is getting so big that the interpretation of the results is becoming very challenging.
OncoKDM supports your analysis and interpretates YOUR OWN DATA. [...] (Read more)
Discover several posters and one oral presentation on clinical benefit and accurate diagnostic with the help on the unique OncoDNA deep Genomic profiling service of patient's tumours. (Metastatic Carcinomas, Carcinomas of Unknown Origin, advanced or metastatic Breast Cancer) [...] (Read more)
Exceptional Event - 21 October 06:30 PM
For our 5th participation at ESMO we celebrated the launch of our extended and powerful gene panel tests.
You enjoyed a delightful evening with OncoDNA team in a typical Bavarian brewery with lots of surprises and discovered the new power of our solutions. [...] (Read more)
Discover the after movie of OncoDNA’s participation to ESMO 2017 in Madrid (SPAIN). Once again, ESMO was the occasion to present our new and innovative solutions to oncologists, it was a real nice experience and we met a lot of new people there who are now our faithful customers.
We organized a private dinner at the Museo Lazaro Galdiano, with our famous Belgian atmosphere. Live again this exceptional moment through this video.
OncoDNA is a private, oncology-focused healthcare technology company that combines advanced, comprehensive testing of all clinically relevant cancer biomarkers (DNA, RNA and protein profiles) from both solid and liquid biopsies with a proprietary cancer treatment knowledge database called OncoKDO™ that continuously ‘learns’ from cutting-edge, validated, scientific and medical advances.
This one-stop-shop analysis and interpretation service gives oncologists actionable results to enable the selection of treatments tailored to an individual patient’s cancer profile. OncoDNA also works in collaboration with the biopharma industry to develop and deliver the treatments of tomorrow by assisting with design, enrolment and assessment of clinical trials as well as by increasing access to approved precision medicines.
The company is based in Gosselies, Belgium, and employs c. 55 employees in four countries.
1, Rue Louis Bréguet
6041 Gosselies, Belgium